Abiomed Inc
ABMD
ABMD was delisted on the 21st of December, 2022.
126 hedge funds and large institutions have $1.05B invested in Abiomed Inc in 2013 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 40 increasing their positions, 49 reducing their positions, and 16 closing their positions.
41% more capital invested
Capital invested by funds: $743M → $1.05B (+$303M)
25% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 16
3% more funds holding
Funds holding: 122 → 126 (+4)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
18% less repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 49
83% less call options, than puts
Call options by funds: $898K | Put options by funds: $5.34M
Top Buyers
Top Sellers
| 1 |
Renaissance Technologies
New York
|
-$4.48M |
| 2 |
D.E. Shaw & Co
New York
|
-$4.03M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
-$3.55M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$2.91M |
| 5 |
NCGI
Next Century Growth Investors
Plymouth,
Minnesota
|
-$2.78M |
ABMD Hedge Fund Activity: Q4 2013 in Review
126 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Abiomed Inc (ABMD) for Q4 2013, worth a combined $1.05B — up 41% from $743M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new ABMD positions and 16 closed out — a net gain of 4 holders — while 40 added to existing stakes and 49 trimmed.
The largest buyer was Cortina Asset Management, opening a new position worth an estimated $6.93M. The largest seller was Renaissance Technologies, cutting an estimated $4.48M.
- 126 institutional investors held Abiomed Inc (ABMD) as of Q4 2013, up from 122 in Q3 2013.
- Funds reported $1.05B of Abiomed Inc stock for Q4 2013, up 41% quarter-over-quarter.
- 20 funds opened new Abiomed Inc positions in Q4 2013 and 16 closed out, a net change of +4 holders.
- The largest Abiomed Inc buyer in Q4 2013 was Cortina Asset Management, an estimated $6.93M added.
- The largest Abiomed Inc seller in Q4 2013 was Renaissance Technologies, an estimated $4.48M sold.
Based on aggregated 13F filings for Q4 2013.